These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Hsi LC, Xi X, Lotan R, Shureiqi I, Lippman SM. Cancer Res; 2004 Dec 01; 64(23):8778-81. PubMed ID: 15574791 [Abstract] [Full Text] [Related]
3. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid. Marchion DC, Bicaku E, Daud AI, Richon V, Sullivan DM, Munster PN. J Cell Biochem; 2004 May 15; 92(2):223-37. PubMed ID: 15108350 [Abstract] [Full Text] [Related]
7. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer. Shi YK, Li ZH, Han XQ, Yi JH, Wang ZH, Hou JL, Feng CR, Fang QH, Wang HH, Zhang PF, Wang FS, Shen J, Wang P. Cancer Chemother Pharmacol; 2010 Nov 15; 66(6):1131-40. PubMed ID: 20838997 [Abstract] [Full Text] [Related]
8. Induction of polyploidy by histone deacetylase inhibitor: a pathway for antitumor effects. Xu WS, Perez G, Ngo L, Gui CY, Marks PA. Cancer Res; 2005 Sep 01; 65(17):7832-9. PubMed ID: 16140952 [Abstract] [Full Text] [Related]
10. Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid. Rikiishi H, Shinohara F, Sato T, Sato Y, Suzuki M, Echigo S. Int J Oncol; 2007 May 01; 30(5):1181-8. PubMed ID: 17390020 [Abstract] [Full Text] [Related]
11. Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines. Sakajiri S, Kumagai T, Kawamata N, Saitoh T, Said JW, Koeffler HP. Exp Hematol; 2005 Jan 01; 33(1):53-61. PubMed ID: 15661398 [Abstract] [Full Text] [Related]
12. Suberoylanilide hydroxamic acid enhances gap junctional intercellular communication via acetylation of histone containing connexin 43 gene locus. Ogawa T, Hayashi T, Tokunou M, Nakachi K, Trosko JE, Chang CC, Yorioka N. Cancer Res; 2005 Nov 01; 65(21):9771-8. PubMed ID: 16266998 [Abstract] [Full Text] [Related]
13. Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1. Tabe Y, Jin L, Contractor R, Gold D, Ruvolo P, Radke S, Xu Y, Tsutusmi-Ishii Y, Miyake K, Miyake N, Kondo S, Ohsaka A, Nagaoka I, Andreeff M, Konopleva M. Cell Death Differ; 2007 Aug 01; 14(8):1443-56. PubMed ID: 17464329 [Abstract] [Full Text] [Related]
15. Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Kelly WK, Marks PA. Nat Clin Pract Oncol; 2005 Mar 01; 2(3):150-7. PubMed ID: 16264908 [Abstract] [Full Text] [Related]